Status: Recruiting
Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
This study will be a 12-month prospective, genotype-blinded longitudinal observational study with current standard of clinical care. This study will enroll 100 pregnant women with OUD at UPMC Hospitals with its high volumes. Because of the observational nature of the study, the anticipated dropout rate will be ≤ 20%. Investigators expect the effective sample size of evaluable patients will be 200 with longitudinal data.
Participants needed: 100
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Ilana HullUpdated: Aug 6, 2026Locations: 1
Eligibility criteria
Pregnant women with OUD and their infant [+6]
Serious maternal medical illness as deemed by the PI that would make it challeng... [+2]